Richard Hamel is the Chief Financial Officer of Arranta and Vibalogics. Richard brings more than 25 years of broad international operations and commercial experience in the CRO and CDMO sectors. He was formerly the Senior Vice President and Chief Financial Officer of United BioSource (UBC) where he had responsibility for the financial operations of the company. During his tenure, he led UBC through significant profitability growth while developing a world class finance function.
Prior to UBC, Richard held roles of increasing responsibility at inVentiv Health, including as Vice President, Controller of the Clinical Segment as well as numerous corporate roles in Treasury and Shared Services. He started his career with E&Y and has worked with a number of companies since then.
Richard holds an MBA from Union College in Schenectady, NY and a BA (Hon) from York University in Toronto, Ontario.